Biocon may gain after receiving EU GMP certification

Capital Market 

has received the EU GMP certification for its Sterile Drug Product manufacturing facility in Bangalore, which was inspected by the European agencies in March 2018. This facility is used for the manufacture of Biocon's portfolio of biosimilars. The announcement was made after market hours yesterday, 4 July 2018.

announced that the meeting of the Board of Directors of the company is scheduled to be held on 9 July 2018, consider and approve the fund raising proposal. The announcement was made after market hours yesterday, 4 July 2018.

KOOV, the leading business, announced that it has reached a conditional agreement with (FLFL), to subscribe for up to a 29.9% stake in The announcement was made after market hours yesterday, 4 July 2018.

Odisha, subsidiary company of has acquired a Brewery unit in Odisha. The facility is expected to be operational in the next 3-4 months. The unit has been acquired at a cost of Rs 46 crore. The capacity of the unit is 42 lakh cases per annum. The company expects additional expenditure of Rs 25-30 crores on the upgradation of the The announcement was made after market hours yesterday, 4 July 2018.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, July 05 2018. 08:42 IST